
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-lineHelicobacter pylorieradication
Author(s) -
Jae Chul Hwang,
Dong Hoon Lee,
Hyuk Yoon,
Cheol Min Shin,
Young Soo Park,
Nayoung Kim
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i35.10234
Subject(s) - rabeprazole , helicobacter pylori , moxifloxacin , medicine , metronidazole , amoxicillin , gastroenterology , urea breath test , clarithromycin , adverse effect , breath test , intention to treat analysis , antibiotics , helicobacter pylori infection , biology , microbiology and biotechnology
To evaluate the efficacy of moxifloxacin-based sequential therapy (MBST) versus hybrid therapy as a first-line treatment for Helicobacter pylori (H. pylori) infection.